Johnson & Johnson is defending its $10 billion settlement proposal to resolve lawsuits alleging that its baby powder caused ovarian cancer. The company is attempting to gain court approval for its third bankruptcy-based resolution through its subsidiary, Red River Talc. Previous attempts to settle the lawsuits in bankruptcy court were rejected, but J&J argues that this effort has broad support from claimants. The case is now before U.S. Bankruptcy Judge Christopher Lopez, who will decide whether to approve the plan or dismiss the bankruptcy. J&J maintains that the settlement provides a fair and efficient resolution for over 62,000 plaintiffs, preventing prolonged litigation.
Opponents of the settlement claim the voting process was manipulated to favor J&J’s preferred outcome. Attorneys representing those against the deal argue that the company selectively accepted votes in favor of the settlement while rejecting dissenting votes. Critics also question whether a financially strong company like J&J should use bankruptcy to shield itself from litigation. The hearing will examine the validity of the votes, the fairness of the proposed settlement, and the broader implications of resolving mass tort claims through bankruptcy. If approved, the settlement would prevent future talc lawsuits against J&J.
